Citation

Johnson E, Kilgore M, Babalonis S. J. Cannabis Res. 2022; 4(1): e28.

Copyright

(Copyright © 2022, Holtzbrinck Springer Nature Publishing Group - BMC)

DOI

10.1186/s42238-022-00140-1

PMID

unavailable

Abstract

The legalization of hemp in the USA has led to tremendous growth in the availability of hemp-derived products, particularly cannabidiol (CBD) products. The lack of regulatory oversight in this industry has resulted in the marketing and sale of CBD products with questionable ingredients and quality. The aim of the current study was to examine the CBD content in 80 commercially available hemp-derived CBD products purchased from online and local retailers. Epidiolex® was also included in the study as a positive control.

Language: en

Keywords

Cannabidiol; CBD; Epidiolex; Label accuracy; Label claim; Regulatory